Prescription drug · ANDA
Phenoxybenzamine Hydrochloride NDC 72603-229
Phenoxybenzamine hydrochloride 10 mg/1 · Capsule · Oral · NorthStar Rx LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72603-229-01 | 72603022901 | 100 CAPSULE in 1 BOTTLE (72603-229-01)Marketed from Oct 1, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Phenoxybenzamine Hydrochloride
- Generic name (nonproprietary)
- phenoxybenzamine hydrochloride
- Active ingredients
- Phenoxybenzamine hydrochloride — 10 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- NorthStar Rx LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215600
- Marketing start
- Marketing end
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 72603-229_fdce371e-19a7-43df-8c4f-6cb9ebb723cbSPL ID fdce371e-19a7-43df-8c4f-6cb9ebb723cbSPL set ID 48a047c0-f409-420b-990a-2cab953a96cdRxCUI 861402UNII X1IEG24OHL
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472603022901followed by a unit qualifier and the quantityPackage 72603-0229-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATION AND USAGE Phenoxybenzamine hydrochloride capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. If tachycardia is excessive, it may be necessary to use a beta -blocking agent concomitantly.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 215600
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Phenoxybenzamine Hydrochloride | Phenoxybenzamine hydrochloride 10 mg/1 | CapsuleOral | Burel Pharmaceuticals, LLC | 35573-473 |
| Phenoxybenzamine Hydrochloride | Phenoxybenzamine hydrochloride 10 mg/1 | CapsuleOral | Aurobindo Pharma Limited | 59651-327 |